Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.
Orienting network dysfunction in progressive multiple sclerosis.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
16 Syndrome in a Patient With Multiple Sclerosis.
Myelin water mapping by spatially regularized longitudinal relaxographic imaging at high magnetic fields.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Clustering of autoimmune diseases in patients with rosacea.
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
Psychiatric symptoms accompanying multiple sclerosis onset: a case report.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas.
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography.
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »